Growth Metrics

Accuray (ARAY) Receivables Refunds (2024 - 2026)

Accuray posted quarterly Receivables Refunds of $7.7 million for Q1 2026, down 30.92% on a QoQ basis from $11.2 million in Q4 2025.

Accuray (ARAY) has 3 years of Receivables Refunds data on file, last reported at $7.7 million in Q1 2026.

  • For the quarter ending Q1 2026, Receivables Refunds changed N/A year-over-year to $7.7 million; the trailing twelve-month figure through Mar 2026 stood at $7.7 million (changed N/A YoY), and the FY2025 full-year result was $841000.0, up 128.53% from the prior year.
  • Receivables Refunds for Q1 2026 stood at $7.7 million, down from $11.2 million in the prior quarter.
  • Across five years, Receivables Refunds topped out at $11.2 million in Q4 2025 and bottomed at $368000.0 in Q2 2024.
  • The 3-year median for Receivables Refunds is $5.6 million (2025), against an average of $5.1 million.
  • Peak annual rise in Receivables Refunds reached 128.53% in 2025, while the deepest fall reached 128.53% in 2025.
  • A 3-year view of Receivables Refunds shows it stood at $368000.0 in 2024, then soared by 2934.51% to $11.2 million in 2025, then slumped by 30.92% to $7.7 million in 2026.
  • The last three Receivables Refunds figures came in at $7.7 million (Q1 2026), $11.2 million (Q4 2025), and $5.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Refund Receivables (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 52.68 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Accuray 47,295.88 -38.49 Mn 25.29 Mn 7.71 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 7.71 Mn
Dec 31, 2025 11.17 Mn
Sep 30, 2025 5.62 Mn
Jun 30, 2025 841,000.00
Jun 30, 2024 368,000.00